Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients
CESARO
1 other identifier
observational
815
1 country
9
Brief Summary
In this prospective, multicenter observational study the investigators capture the perioperative course of peripheral cholinesterase activity. The focus is the perioperative inflammation causing postoperative delirium. Therefore we measure the activity of Acetylcholine-Esterase and Butyrylcholine-Esterase in whole blood of adults in the perioperative context. Early postoperative delirium will be detected by Nu-DESC in the Recovery Room or the Postanaesthesia-Care-Unit. The course of the peripheral cholinesterase activity will be compared with the incidence of postoperative delirium and other clinical dysfunctions. We follow up the patients for up to five years regarding Delirum, comorbidities and mortality data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2013
Typical duration for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 15, 2013
CompletedFirst Posted
Study publicly available on registry
October 17, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedAugust 21, 2019
August 1, 2019
2.8 years
October 15, 2013
August 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Delirium
Postoperative Delirium (measured by Nursing Delirium Screening Scale)
Participants will be followed in the sample period, an exspected average of three days
Secondary Outcomes (11)
Organ Dysfunctions
Participants will be followed in the sample period, an exspected average of three days
Concomitant medication
Participants will be followed in the three postoperative days sample period
Postoperative Pain
Participants will be followed in the three postoperative days sample period
Duration of Intensive Care Unit Stay
Participants will be followed in the sample period, an exspected average of seven days
Duration of Hospital Stay
Participants will be followed in the sample period, an exspected average of four weeks
- +6 more secondary outcomes
Study Arms (1)
Surgical patients
Adult male and female patients undergoing surgery
Eligibility Criteria
Adult, elective surgery patients of both gender
You may qualify if:
- Male and female patients with age 18 years and above scheduled for surgery with planned stay in Recovery Room or Postanesthesia-Care-Unit
- Offered patient information and written informed consent
- In-hospital stay for at least 24 hours
You may not qualify if:
- Patients with known pseudocholinesterase deficiency
- Participation in prospective intervention studies during the study period
- Analphabetism
- Unability of German and English language use
- Anacusis or Hypoacusis with hearing aid device, Amaurosis
- Lacking willingness to save and hand out data within the study
- Accommodation in an institution due to an official or judicial order
- Coworker of the clinic (study center)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin
Berlin, 13353, Germany
Department of Anesthesia, Klinik für MIC
Berlin, 14129, Germany
Clinic for Anaesthesiology, Intensive Care Medicine, Palliative Medicine and Pain Medicine, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil
Bochum, 44789, Germany
Department of Anesthesiology, Universitätsklinikum Heidelberg
Heidelberg, 69120, Germany
Department of Anesthesiology, Klinikum Großhadern of the Ludwig Maximilians University of Munich
München, 81377, Germany
Department of Anesthesiology, Universitätsklinikum Regensburg
Regensburg, 93053, Germany
Department of Anesthesiology, Universitätsklinikum Ulm
Ulm, 89081, Germany
Department of anesthesiology and intensive care medicine
Wetzlar, 35578, Germany
Department of Anaesthesia and Critical Care, Universitätsklinikum Würzburg
Würzburg, 97080, Germany
Related Publications (2)
Muller A, Olbert M, Heymann A, Zahn PK, Plaschke K, von Dossow V, Bitzinger D, Barth E, Meister M, Kranke P, Herrmann C, Wernecke KD, Spies CD. Relevance of peripheral cholinesterase activity on postoperative delirium in adult surgical patients (CESARO): A prospective observational cohort study. Eur J Anaesthesiol. 2019 Feb;36(2):114-122. doi: 10.1097/EJA.0000000000000888.
PMID: 30431498RESULTMichels B, Holzamer A, Graf BM, Bredthauer A, Petermichl W, Muller A, Zausig YA, Bitzinger DI. Butyrylcholinesterase as a perioperative complication marker in patients after transcatheter aortic valve implantation: a prospective observational study. BMJ Open. 2021 Jul 6;11(7):e042857. doi: 10.1136/bmjopen-2020-042857.
PMID: 34230011DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Claudia Spies, MD
Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Anesthesiology and Intensive Care Medicine CVK/CCM, Charite - Universitätsmedizin Berlin, Germany
Study Record Dates
First Submitted
October 15, 2013
First Posted
October 17, 2013
Study Start
October 1, 2013
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
August 21, 2019
Record last verified: 2019-08